1. FDA Requires Labeling Changes For Opioids To Include Information About Naloxone
The FDA has announced that it is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder to include new recommendations about naloxone to the prescribing information. (psychiatryadvisor.com)
2. PTSD Therapy Doesn’t Trigger Drug Relapse In Addiction Patients
Talk therapy for post-traumatic stress disorder (PTSD) doesn’t appear to increase addiction treatment patients’ risk of relapse, a small new study says. (usnews.com)
3. Alcohol Abuse May Raise Risk Of Death In Patients With Abnormal Heart Rhythms
When patients under age 54 were hospitalized with abnormal heart rhythms, those who abused alcohol were 72% more likely to die before being discharged (medicalxpress.com)
4. Alberta Announces $10m For Addiction Recovery Communities In Lethbridge County, Blood Tribe First Nation
In total, 125 long-term resident addiction treatment beds will be created: 75 on the Blood Tribe and 50 in Lethbridge County. (globalnews.ca)
5. Increase In Medical Cannabis Prescriptions In The Czech Republic
At the beginning of 2020, the Czech Republic Ministry of Health announced that it would introduce medical cannabis subsidies, with a 90% reimbursement for medicinal cannabis products available from public health insurance. (prohibitionpartners.com)
Visit Previous week Addiction Recovery News Around the World
- https://www.addictionaide.com/weekly-roundup/addiction-recovery-weekly-roundup-july-4-week
- https://www.addictionaide.com/weekly-roundup/addiction-recovery-weekly-roundup-july-3-week
- https://www.addictionaide.com/weekly-roundup/addiction-recovery-weekly-roundup-july-2-week
- https://www.addictionaide.com/weekly-roundup/addiction-recovery-weekly-roundup-july-1-week
- https://www.addictionaide.com/weekly-roundup/addiction-recovery-weekly-roundup-june-4-week
